CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 155 enrolled
Drug / intervention
Imagio (IUS+OA) +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03708393
NCT03708393N/ACompleted

Imagio Feasibility Multi-Reader, Multi-Case Study of Optoacoustic Images Versus Imagio Ultrasound to Guide Decision to Biopsy

Seno Medical Instruments Inc.·interventional·Posted Oct 17, 2018·Updated Aug 6, 2021

In Brief

A clinical study evaluating Imagio (IUS+OA), Imagio Ultrasound, and 1 other intervention for Breast Cancer. Completed, enrolled 155 participants across 1 site.

Detailed Summary

Controlled, blinded, multi-reader, multi-case study

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedOct 17, 2018
Enrollment StartNov 13, 2018
Primary CompletionDec 9, 2018
TodayJul 2, 2026
Enrollment to primary: 26 daysPosted 7.7 years ago

Interventions

Imagio (IUS+OA)device

The Imagio ultrasound and opto-acoustic images to be reviewed as part of the reader study

Imagio Ultrasounddevice

Imagio ultrasound images to be reviewed as part of the reader study

Mammographydevice

Mammography images as available per standard of care